MedTrace Logo

Sensitivity and Specificity of NGAL in an Emergency Room Population

NCT00786708 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2304

Last updated 2014-02-10

No results posted yet for this study

Summary

Hypothesis: In patients that present to an urban emergency room, a single urine neutrophil gelatinase-associated lipocalin (NGAL) measurement can classify their kidney disease as stable chronic kidney disease, acute tubular necrosis, urinary outlet obstruction or pre-renal azotemia.

Conditions

  • Azotemia
  • Renal Insufficiency, Chronic
  • Renal Failure, Acute
  • Hydronephrosis

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • Charite University, Berlin, Germany

    collaborator OTHER

  • Staten Island University Hospital

    collaborator OTHER

  • Columbia University

    lead OTHER

Principal Investigators

  • Thomas L. Nickolas, MD, MS · Columbia University

  • Jonathan Barasch, MD, PhD · Columbia University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2009-12-31
Completion
2013-07-31

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00786708 on ClinicalTrials.gov